Agenda is subject to change

Wednesday, April 21

   
11:00am - 12:00pm

Keynote - The Future of Post Pandemic Healthcare: Light at the End of the Tunnel or an Approaching Train
Jacque Sokolov, MD, CEO & Chairman, SSB Solutions

 
12:00pm - 1:00pm Top 10 Considerations to Assure Successful Physician/Health System Affiliation (Plus Impact on Managed Care Contracts)
Max Reiboldt, CPA, President/CEO, Coker Group and Thomas Anthony, Partner, Frost Brown Todd
 
1:00pm - 2:00pm Lunch  
2:00pm - 3:00pm Optimizing Your Managed Care Contracts in the Era of Price Transparency, Value-Based Contracting and COVID-19: What Providers and Payers Need to Know
David Gregory, Principal, Baker Tilly, Alan Lieber, President, Overlook Medical Center and Vice President, Atlantic Health System, David Dafilou, Vice President & CAO of CIN, Capital Health System
 
3:00pm - 4:00pm A Collaborative Payer/Provider Approach to Health Equity
Steven J. Serra, MD, MPH, MSc, Executive Director, Physician Consultants, Aetna, Plan Sponsor Insights
 
     

Thursday, April 22

   
 
HEALTH MANAGEMENT TRACK
 

ONCOLOGY TRACK
 
10:30 am - 11:30 am Evolving Treatment Paradigms in the Management of Multiple Sclerosis
Benjamin M. Greenberg, MD, Director, Perot Foundation Neurosciences Translational Research Center, Professor, Department of Neurology, UT Southwestern
Recent Advances in the Treatment and Management of Acute Myeloid Leukemia (AML): Expert Perspectives for Improved Clinical and Economic Outcomes
Harry P. Erba, MD, PhD, Professor of Medicine, Director, Leukemia Program, Duke University Medical Center
 
11:30 am - 12:30 pm New Frontiers in the Treatment and Management of Alzheimer's Disease: Expert Perspectives on the Role of Emerging Therapies
Marc Agronin, MD, Senior Vice President for Behavioral Health, Miami Jewish Health
Best Practices in the Treatment and Management of Metastatic Breast Cancer: Essential Strategies for Improved Clinical and Economic Outcomes
Filipa Lynce, MD, Breast Medical Oncologist, Dana Farber Cancer Institute
12:30 pm - 1:30 pm Break Break
1:30 pm - 2:30 pm Navigating Advances in the Treatment of Pulmonary Arterial Hypertension: Understanding Multidisciplinary Approaches to Optimize Outcomes
Richard N. Channick, MD, Saul Brandman Endowed Chair in Pulmonary Arterial Hypertension, Professor of Medicine, Pulmonary and Critical Care Division, David Geffen School of Medicine at UCLA
Patient-Focused Treatment Decisions in Advanced Renal Cell Carcinoma (RCC): Expert Strategies on New And Emerging Combinations
Toni K. Choueiri, MD, Director, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Jerome and Nancy Kohlberg Professor of Medicine, Harvard Medical School
2:30 pm - 3:30 pm Recent Therapeutic Strategies for Psoriatic Arthritis: Optimal Management for Personalized Patient Care
Leonard H. Calabrese, DO, Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, R.J. Fasenmyer Chair of Clinical Immunology, Cleveland Clinic
Evolving Considerations in the Treatment and Management of Chronic Lymphocytic Leukemia (CLL)
Farrukh T. Awan, MD, Associate Professor of Internal Medicine, Director of Lymphoid Malignancies Program, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center
3:30 pm - 3:40 pm Break Break
3:40 pm - 4:40 pm Navigating an Increasingly Complex Treatment Paradigm in the Management of HIV: Individualized Therapy for Improved Clinical and Economic Outcomes
Gary Owens, MD, President, Gary Owens Associates
Novel Treatment Advances and Approaches in the Management of HER2-Positive Advanced Breast Cancer: Expert Strategies on the Role of New and Emerging Therapies
Mark D. Pegram, MD, Director, Breast Cancer Oncology Program, Suzy Yuan-Huey Hung Endowed Professor of Medical Oncology, Stanford University School of Medicine, Stanford Cancer Institute
4:40 pm - 5:40 pm Navigating an Increasingly Complex Treatment Paradigm in the Management of Type 2 Diabetes: Optimizing Cardiovascular and Renal Outcomes with SGLT2 Inhibitors
Richard E. Pratley, MD, Samuel E. Crockett Chair in Diabetes Research, Medical Director, AdventHealth Diabetes Institute, Adjunct Professor of Medicine, Johns Hopkins University School of Medicine

Advanced Treatment Strategies in Prostate Cancer: A Closer Look at the Current and Emerging Therapeutic Options
Robert Dreicer, MD, MS, Section Head Medical Oncology, Deputy Director, University of Virginia Cancer Center, Co-Director Paul Mellon Urologic Cancer Institute, Professor of Medicine and Urology, University of Virginia School of Medicine

     
Friday, April 23    
 
HEALTH MANAGEMENT TRACK
 

ONCOLOGY TRACK
 
10:30 am - 11:30 am A Closer Look at the Latest Advances in the Treatment and Management of Ankylosing Spondylitis
Joerg Ermann, MD, Associate Physician, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Instructor in Medicine, Harvard Medical School
Meeting the Challenges of Integrating Biosimilars in the Healthcare Treatment Paradigm
Sanjiv S Agarwala, MD, Professor, Temple University School of Medicine
11:30 am - 12:30 pm Recent Therapeutic Approaches for Migraine Management: The Latest Developments in Diagnosis and Prevention
Andrew Charles, MD, Professor of Neurology, Director, UCLA Goldberg Migraine Program, Meyer and Renee Luskin Chair in Migraine and Headache Studies, David Geffen School of Medicine at UCLA
Recent Advances in the Treatment and Management of Relapsed/Refractory Multiple Myeloma: Expert Perspectives on the Role of New Therapies
Ravi Vij, MD, MBA, Professor, Section of BMT and Leukemia, Division of Medical Oncology, Washington University School of Medicine
12:30 pm - 1:30 pm
 
Break Break
1:30 pm - 2:30 pm New Horizons in the Treatment and Management of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Expert Perspectives on Immunoglobulin Therapy
Chafic Karam, MD, Neurologist, Penn Neuroscience Center, Perelman Center for Advanced Medicine
Best Practices in the Treatment and Management of Ovarian Cancer: An In-Depth Look at the Evolving Role of PARP Inhibitors
Richard T. Penson, MD, MRCP, Associate Professor of Medicine, Harvard Medical School, Clinical Director Medical Gyn Onc, Massachusetts General Hospital, IRB Chair, Dana-Farber / Harvard Cancer Center
2:30 pm - 3:30 pm Exploring the Latest Guidelines and Evidence of IBD Management: An Update in Diagnosis and Treatment
Francis A. Farraye, MD, MSc, Director, Inflammatory Bowel Disease Center, Professor of Medicine, Department of Gastroenterology and Hepatology, Mayo Clinic
Navigating an Increasingly Complex Treatment Landscape in the Management of Non-Small Cell Lung Cancer (NSCLC)
Jack West, MD, Associate Clinical Professor, City of Hope Cancer Center Clinical, Executive Director, AccessHope
3:30 pm - 3:40 pm Break Break
3:40 pm - 4:40 pm New Horizons in the Treatment of Psoriasis: Key Strategies to Target Optimal Patient Outcomes
Junko Takeshita, MD, PhD, MSCE, Assistant Professor of Dermatology and Epidemiology, University of Pennsylvania Perelman School of Medicine
Evolving Considerations in the Treatment and Management of Metastatic Melanoma: Expert Strategies on Immune Checkpoint Inhibitors
Sanjiv S Agarwala, MD, Professor, Temple University School of Medicine
4:40 pm - 5:40 pm Evolving Considerations in the Treatment and Management of Hereditary Angioedema (HAE): Managed Care Strategies in an Evolving Treatment Paradigm
Marc Riedl, MD, MS, Professor of Medicine, Clinical Director - US HAEA Angioedema Center, Clinical Service Chief & Training Program Director, Division of Rheumatology, Allergy & Immunology, University of California, San Diego
Patient-Focused Treatment Decisions in Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC): A Closer Look at the Evolving Role of Immunotherapy
Gary Owens, President, Gary Owens Associates
 


Agenda is subject to change